Evaluating The Clinical Effectiveness of Trastuzumab Emtansine (T-DM1) Versus All Other Treatments For Previously Treated, Unresectable, HER2-Positive Metastatic Breast Cancer (MBC)- A Mixed Treatment Comparison (MTC)
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.108
https://www.valueinhealthjournal.com/article/S1098-3015(17)30442-4/fulltext
Title :
Evaluating The Clinical Effectiveness of Trastuzumab Emtansine (T-DM1) Versus All Other Treatments For Previously Treated, Unresectable, HER2-Positive Metastatic Breast Cancer (MBC)- A Mixed Treatment Comparison (MTC)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30442-4&doi=10.1016/j.jval.2017.08.108
First page :
A416
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
89